141st APHA Annual Meeting and Exposition

Home Events & Meetings Annual Meeting Schedule & Program

Recorded Annual Meeting Presentations (RAMP) are now available for purchase.
Only $90 for presenters, $140 for registered attendees and $200 for non-attendees.

Online Program

295780
Addressing Diabetes in Southern Africa


Monday, November 4, 2013 : 8:48 a.m. - 9:06 a.m.

Ephraim Gwebu, PhD, Elizabeth City State University, Elizabeth City, NC
     
The South African Center for Diabetes and Endocrinology describes this epidemic as the “diabetes tsunami” that is engulfing Southern Africa. Six percent (3.5 million) of South Africans suffer from diabetes and over 5 million have pre-diabetes. Diabetes management and treatment are very costly. In Southern Africa, urbanization and its concomitant dietary/lifestyle changes are positive correlates with diabetes. From our study in South Africa, we have developed simple and cheap tools for use by health care workers in the impoverished sectors to identify pre-diabetes status in order to implement interventions that forestall onset of diabetes.

Learning Areas:

Planning of health education strategies, interventions, and programs
Public health or related public policy

Learning Objectives:
Describe the challenges of addressing diabetes in Southern Africa. Describe the roles of public health workers in addressing diabetes in low-income countries.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: As Program Director of the Elizabeth City State University Minority Health International Research Training Program, I am the principal investigator of a study that examines the following in Southern Africa: Risk Factors for type 2 diabetes, Risk Factors for Insulin Resistance among nondiabetics, Waist Circumference and diabetes risk score that are biomarkers for pre-diabetes status, Diabetes Self-Management Practices among diabetics.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3005.0: Late Breaking Developments in Public Health